Institutional
9 de August de 2017
Published ANVISA’s new rule relative to the prior consent for the granting of a patent for pharmaceutical products and processes
Valid since August 10 2017 – date of its publication on the Official Federal Gazette – this new rule confirms all the principals and procedures already stated on Normative Instruction Nº 01, from May 31 2017.
In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com
Back
Share:
Last related news
27 de October de 2025
Legal 500 recognizes Kasznar Leonardos as Leading Firm in Latin America
We are honored to announce that our partners Gabriel Leonardos, Elisabeth Kasznar, and Rafael Lacaz have been recognized as Leading Partners by … Legal 500 recognizes Kasznar Leonardos as Leading Firm in Latin America
23 de October de 2025
Kasznar Leonardos partners are ranked as IAM Global Leaders 2026
We are proud to announce that our partners Gabriel Leonardos and Tatiana Silveira have been recognized as IAM Global Leaders 2026! Each … Kasznar Leonardos partners are ranked as IAM Global Leaders 2026
22 de October de 2025
Elisabeth Kasznar is recognized as Trademarks Lawyer of the Year by Lexology Index Awards
We are proud to announce that our partner Elisabeth Kasznar has been recognized as IP – Trademarks Lawyer of the Year by … Elisabeth Kasznar is recognized as Trademarks Lawyer of the Year by Lexology Index Awards